Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$143.415
Market cap
$345.29B
P/E Ratio
23.78
Dividend/share
$4.91
EPS
$6.03
Enterprise value
$361.06B
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
The gross profit is up by 4.7% YoY
JNJ's revenue is up by 4.6% year-on-year
Johnson & Johnson's debt has increased by 19% YoY but it has decreased by 14% from the previous quarter
JNJ's price to earnings (P/E) is 69% higher than its last 4 quarters average of 14.5 and 10% higher than its 5-year quarterly average of 22.3
Johnson & Johnson's net income has shrunk by 61% QoQ and by 58% YoY
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$345.29B
Enterprise value
$361.06B
Price to earnings (P/E)
23.78
Price to book (P/B)
4.92
Price to sales (P/S)
4.32
EV/EBIT
20.79
EV/EBITDA
14.65
EV/Sales
4.52
Revenue
$79.83B
Gross profit
$56.15B
Net income
$14.68B
EBIT
$17.37B
EBITDA
$24.65B
Free cash flow
$20.75B
Per share
Balance sheet
Liquidity
EPS
$6.03
EPS diluted
$5.96
Free cash flow per share
$8.62
Book value per share
$29.14
Revenue per share
$33.16
TBVPS
$39.05
Total assets
$178.29B
Total liabilities
$108.13B
Debt
$35.75B
Equity
$70.16B
Working capital
$1.49B
Debt to equity
0.51
Current ratio
1.03
Quick ratio
0.7
Net debt/EBITDA
0.64
Margins
Efficiency
Dividend
EBITDA margin
30.9%
Gross margin
70.3%
Net margin
18.4%
Operating margin
24.7%
Return on assets
8.4%
Return on equity
20.9%
Return on invested capital
29.4%
Return on capital employed
13.7%
Return on sales
21.8%
Dividend yield
3.42%
DPS
$4.91
Payout ratio
81.4%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
-3.2%
1 week
-1.07%
1 month
-0.73%
1 year
-11.73%
YTD
-0.83%
QTD
-0.83%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$79.83B
Gross profit
$56.15B
Operating income
$19.75B
Net income
$14.68B
Gross margin
70.3%
Net margin
18.4%
Johnson & Johnson's net margin has plunged by 62% from the previous quarter and by 59% YoY
Johnson & Johnson's net income has shrunk by 61% QoQ and by 58% YoY
The gross profit is up by 4.7% YoY
JNJ's revenue is up by 4.6% year-on-year
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
23.78
P/B
4.92
P/S
4.32
EV/EBIT
20.79
EV/EBITDA
14.65
EV/Sales
4.52
JNJ's price to earnings (P/E) is 69% higher than its last 4 quarters average of 14.5 and 10% higher than its 5-year quarterly average of 22.3
The EPS has plunged by 60% from the previous quarter and by 56% YoY
JNJ's price to book (P/B) is 14% less than its 5-year quarterly average of 5.9 and 4.2% less than its last 4 quarters average of 5.3
The price to sales (P/S) is 12% less than the 5-year quarterly average of 5.1 and 4.9% less than the last 4 quarters average of 4.7
JNJ's revenue is up by 4.6% year-on-year
Efficiency
How efficient is Johnson & Johnson business performance
The return on assets has dropped by 62% since the previous quarter and by 55% year-on-year
The company's return on equity has shrunk by 61% QoQ and by 56% YoY
The ROS has plunged by 58% from the previous quarter and by 55% YoY
Johnson & Johnson's return on invested capital has shrunk by 57% QoQ and by 43% YoY
Dividends
What is JNJ's dividend history
DPS
$4.91
Dividend yield
3.42%
Payout ratio
81.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 65% greater than its total liabilities
The quick ratio has decreased by 19% YoY and by 9% QoQ
JNJ's current ratio is down by 15% year-on-year and by 3.7% since the previous quarter
Johnson & Johnson's debt is 49% less than its equity
The company's debt to equity rose by 21% YoY but it fell by 12% QoQ
Johnson & Johnson's debt has increased by 19% YoY but it has decreased by 14% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.